Doctor profile · Federal record
Dr. Matthew Pabis, M.D.
Family Medicine Physician (CMS: Family Practice) · New York, NY
- NPI 1376981589
- Accepts Medicare
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
57 St Mark's Place
New York, NY 100034318
(212) 982-3470 - Mailing address
-
201 E 69Th St, Ste 2C
New York, NY 100215465
Credentials & registration
- NPI registered
- June 2013 — 13 yrs on file
- Profile last updated
- January 9, 2018
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- New York #285645
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1376981589. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
239
Distinct HCPCS
2
Medicare allowed
$27,152
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 174 | 55 | $102 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 65 | 32 | $144 |
In context: peer comparison
Among 126 peers in this city , average services per provider: 76. This provider delivers 3.1× the peer median.Open Payments
Industry payments received
All-time total
$61,291
Transactions
209
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Alkermes, Inc. | 48 | $30,387.61 | |
| Axsome Therapeutics, Inc. | 26 | $19,053.67 | |
| Gilead Sciences, Inc. | 46 | $7,043.00 | |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $2,280.00 | |
| ABBVIE INC. | 14 | $579.96 | |
| ViiV Healthcare Company | 11 | $310.15 | |
| Lundbeck LLC | 20 | $290.58 | |
| GlaxoSmithKline, LLC. | 9 | $246.64 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $209.31 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $142.17 | |
| Janssen Pharmaceuticals, Inc | 1 | $129.33 | |
| Vanda Pharmaceuticals Inc. | 4 | $91.49 | |
| Otsuka America Pharmaceutical, Inc. | 3 | $75.98 | |
| AstraZeneca Pharmaceuticals LP | 4 | $75.97 | |
| Teva Pharmaceuticals USA, Inc. | 3 | $74.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,515
Patients
311
Total drug cost
$239,730
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 314 | 40 | $9,883 |
| Clonazepam | Generic | 146 | 24 | $2,066 |
| Ozempic (Semaglutide) | Brand | 107 | 21 | $130,042 |
| Zolpidem Tartrate | Generic | 107 | 22 | $656 |
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | Brand | 97 | 15 | $3,534 |
| Gabapentin | Generic | 90 | 35 | $2,229 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 89 | 19 | $1,641 |
| Alprazolam | Generic | 87 | 16 | $573 |
| Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl) | Brand | 87 | 11 | $25,598 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 81 | 21 | $3,455 |
Frequently asked questions
What is Dr. Matthew Pabis's medical specialty?
Dr. Matthew Pabis practices Family Medicine Physician in New York, NY.
Where does Dr. Matthew Pabis practice?
Dr. Matthew Pabis practices at 57 St Mark's Place, New York, NY 100034318. Office phone: 2129823470.
What is Dr. Matthew Pabis's NPI?
Dr. Matthew Pabis's National Provider Identifier (NPI) is 1376981589, issued by NPPES.
Does Dr. Matthew Pabis accept Medicare assignment?
Yes. Dr. Matthew Pabis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Pabis commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.